Follow-up of newborns treated with extracorporeal membrane oxygenation: a nationwide evaluation at 5 years of age by Hanekamp, Manon N et al.
Open Access
Available online http://ccforum.com/content/10/5/R127
Page 1 of 11
(page number not for citation purposes)
Vol 10 No 5 Research
Follow-up of newborns treated with extracorporeal membrane 
oxygenation: a nationwide evaluation at 5 years of age
Manon N Hanekamp1, Petra Mazer1, Monique HM van der Cammen-van Zijp2, Boudien JM van 
Kessel-Feddema3, Maria WG Nijhuis-van der Sanden4, Simone Knuijt5, Jessica LA Zegers-
Verstraeten6, Saskia J Gischler1, Dick Tibboel1 and Louis AA Kollée6
1Department of Pediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital. Rotterdam, The Netherlands
2Department of Physical Therapy, Subdivision Peadiatric Physiotherapy, Erasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The 
Netherland
3Department of Medical Psychology, Radboud University Nijmegen Medical Centre, The Netherlands
4Department of Paediatric Physical Therapy, Radboud University Nijmegen Medical Centre, The Netherlands
5Department of Allied Health Care, Speech and Language Pathology, Radboud University Nijmegen Medical Centre, The Netherlands
6Department of Neonatology, Radboud University Nijmegen Medical Centre, The Netherlands
Corresponding author: Dick Tibboel, d.tibboel@erasmusmc.nl
Received: 5 Jun 2006 Revisions requested: 12 Jun 2006 Revisions received: 3 Aug 2006 Accepted: 11 Sep 2006 Published: 11 Sep 2006
Critical Care 2006, 10:R127 (doi:10.1186/cc5039)
This article is online at: http://ccforum.com/content/10/5/R127
© 2006 Hanekamp et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction Extracorporeal membrane oxygenation (ECMO) is
a supportive cardiopulmonary bypass technique for babies with
acute reversible cardiorespiratory failure. We assessed
morbidity in ECMO survivors at the age of five years, when they
start primary school and major decisions for their school careers
must be made.
Methods Five-year-old neonatal venoarterial-ECMO survivors
from the two designated ECMO centres in The Netherlands
(Erasmus MC – Sophia Children's Hospital in Rotterdam, and
University Medical Center Nijmegen) were assessed within the
framework of an extensive follow-up programme. The protocol
included medical assessment, neuromotor assessment, and
psychological assessment by means of parent and teacher
questionnaires.
Results Seventeen of the 98 children included in the analysis
(17%) were found to have neurological deficits. Six of those 17
(6% of the total) showed major disability. Two of those six
children had a chromosomal abnormality. Three were mentally
retarded and profoundly impaired. The sixth child had a right-
sided hemiplegia. These six children did not undergo
neuromotor assessment. Twenty-four of the remaining 92
children (26%) showed motor difficulties: 15% actually had a
motor problem and 11% were at risk for this. Cognitive delay
was identified in 11 children (14%). The mean IQ score was
within the normal range (IQ = 100.5).
Conclusion Neonatal ECMO in The Netherlands was found to
be associated with considerable morbidity at five years of age. It
appeared feasible to have as many as 87% of survivors
participate in follow-up assessment, due to cooperation
between two centres and small travelling distances. Objective
evaluation of the long-term morbidity associated with the
application of this highly invasive technology in the immediate
neonatal period requires an interdisciplinary follow-up
programme with nationwide consensus on timing and actual
testing protocol.
Introduction
Extracorporeal membrane oxygenation (ECMO) is a cardiopul-
monary bypass technique for providing life support in acute
reversible cardiorespiratory failure when conventional man-
agement is not successful. Most patients receiving ECMO
support are neonates suffering from persistent pulmonary
hypertension of the newborn, primary or secondary to meco-
nium aspiration syndrome, sepsis, or congenital diaphragmatic
hernia. Worldwide, over 18,700 neonates have been treated
CDH = congenital diaphragmatic hernia; ECMO = extracorporeal membrane oxygenation; IQ = intelligence quotient; M-ABC = Movement Assess-
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with ECMO for respiratory problems, and the overall survival
rate was 77% [1].
The UK Collaborative ECMO Trial Group in 1996 presented
the results of a randomised controlled clinical trial, showing a
significant survival benefit of ECMO, without a concomitant
rise in severe disability at one year of age [2,3]. Even for the
35 neonates with congenital diaphragmatic hernia (CDH) the
risk of death was reduced (relative risk, 0.72; 95% confidence
interval, 0.54–0.06; P = 0.03). Of the 18 neonates with CDH
allocated to ECMO, however, 14 died (one after discharge)
and only three children survived to age 4 years. All 17 infants
in the conventional management arm died before discharge
[4]. No other therapeutic intervention (that is to say, high-fre-
quency oscillatory ventilation, surfactant, and inhaled nitric
oxide) for neonatal acute respiratory failure has such a positive
impact on mortality and morbidity [5].
Nevertheless, the severity of illness of potential candidates for
ECMO, as well as the risks associated with the procedure
itself, places the ECMO survivor at high risk of developing
brain injury and subsequent function deficits. All patients
receiving ECMO support have suffered from severe respira-
tory failure prior to treatment. Prolonged episodes of severe
hypoxaemia may occur, despite the administration of 100%
oxygen. The inevitable high ventilatory pressures and hyper-
ventilation may cause alterations in cerebral blood flow [6,7].
In venoarterial ECMO the right common carotid artery and
right internal jugular vein are cannulated and subsequently
ligated after bypass is finished. Finally, the heparin that is
administered to prevent the blood from clotting might cause
intracranial haemorrhage as a confounder for long-term mor-
bidity. It is not easy, therefore, to predict the long-term out-
come of neonates treated with ECMO.
The few reports on structural follow-up of ECMO survivors
either describe infants up to age 2 or patients from a single
centre with wide age distribution [3,8-15]. The reports point
out that logistic problems may prevent patients from being
available for predetermined, structural evaluation. Major disa-
bilities in terms of severe developmental delay or neuromotor
disabilities were reported in some 20% of ECMO survivors
[3,8,10,12]. The range of morbidity widens with evaluation
after age one, when assessment of cognitive skills, coordina-
tion, behavioural difficulties, and sensory loss can be more pre-
cise [16]. Long-term longitudinal follow-up of these children
therefore seems essential for placing ECMO results in per-
spective. Only two studies describe longitudinal neurodevel-
opmental evaluation at school age [16,17]. Although surviving
children treated for severe life-threatening respiratory failure
soon after birth show considerable long-term morbidity, the
results of the UK ECMO trial point to a favourable profile of
long-term morbidity in the group assigned to ECMO [16].
Glass and colleagues reported a 61% response rate; 25% did
not participate because of the long travelling distances in the
USA [17]. Neonatal ECMO in The Netherlands is provided in
two designated centres only, authorised by the Dutch govern-
ment. All parents of ECMO survivors are invited to enter their
child into a redesigned follow-up programme. High response
rates are feasible because travelling distances are short in The
Netherlands and regionalised high-risk perinatal care, includ-
ing ECMO, is available. The children are scheduled to undergo
assessment at ages 6, 12, 18 and 24 months and 5, 8 and 12
years. In the present paper we present the follow-up findings
at age 5 years, when children are in the first year or second
year of primary school and major decisions for their future
school careers must be made.
Materials and methods
Patients
The study population included five-year-old neonatal venoarte-
rial ECMO survivors from both ECMO centres in The Nether-
lands (the Erasmus MC – Sophia Children's Hospital
Rotterdam and University Medical Center Nijmegen). The
patients were seen either between May 2001 and December
2003 (Rotterdam) or between March 1998 and December
2003 (Nijmegen). According to national consensus on neona-
tal follow-up and the obligation to provide these data based on
reports of the Dutch Ministry of Health, the assessment proto-
col is the standard of care in The Netherlands following
ECMO. As a consequence IRB approval was waived, while all
parents were routinely informed about the long-term follow-up
programme in the neonatal period of life of their child.
Assessment protocol
Complete assessment included a one hour medical assess-
ment by a paediatrician/neonatologist experienced in the fol-
low-up evaluation, a 1.5-hour neuromotor assessment by a
paediatric physiotherapist, and a three hour neuropsychologi-
cal assessment by a psychologist or psychological test assist-
ant (Table 1). In Nijmegen a speech therapist assessed
speech and language development, and in Rotterdam the psy-
chologist performed the neuropsychological assessment.
The complete assessment took place in one day. The
sequence of the different assessments could vary for logistic
reasons.
In addition, one month before assessment, the parents were
invited to complete questionnaires on parental socio-eco-
nomic status and the child's current general health and
behaviour.
Perinatal characteristics such as birthweight, gestational age,
age at start of ECMO, duration of ECMO, primary diagnosis,
and possible intracranial abnormalities were obtained from
each centre's ECMO registry and are included in the Extracor-
poreal Life Support Organisation Registry Report [1].Available online http://ccforum.com/content/10/5/R127
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Medical assessment
Medical assessment consisted of taking the child's medical
history, the measurement of growth parameters, and a stand-
ard physical examination followed by a standard neurological
examination. The length and weight were expressed as the
standard deviation (SD) score using the Dutch Growth Ana-
lyser, version 2.0 (Dutch Growth Foundation, Rotterdam,
Netherlands). The results of the neurological examination were
categorised into normal (no neurological abnormalities), minor
neurological dysfunction (neurological abnormalities without
influence on normal posture or movement), and major neuro-
logical dysfunction (neurological abnormalities with abnormal
posture or movements, including seizure disorders).
Neuromotor assessment
The Movement Assessment Battery for Children (M-ABC) was
used to measure motor functioning [18]. A Dutch standardisa-
tion study has shown that the original norm scores and cut off
points can also be applied to Dutch children. Good validity
and reliability have been demonstrated [18,19].
The M-ABC was developed for children aged 4–12 years. The
measure has four age-related item sets, each consisting of
eight items: three manual dexterity items (a time-related task
for each hand separately, a bimanual coordination task, and a
graphical task with the preferred hand), two ball skill items (a
task of catching a moving object and a task of aiming at a
goal), and three balance items (static balance, dynamic bal-
ance while moving fast, and dynamic balance while moving
slowly). Scores may range from 0 to 5 for each item. A high
score on the M-ABC indicates poor performance. The total
impairment score, which is the sum of the item scores, was
calculated as a percentile score. A score below the 5th per-
centile is indicative of a motor problem, a score between the
5th and 15th percentile means borderline performance, and a
score above the 15th percentile is a normal score [18].
Exercise test
The children seen in Rotterdam performed a graded, maximum
exercise test using a motor-driven treadmill. The treadmill was
programmed for increases in angle of inclination and speed
every three minutes according to the Bruce protocol [20,21].
The Bruce protocol starts with a speed of 2.7 km/hour at an
incline of 10%. The children are encouraged to perform to vol-
untary exhaustion. The maximal endurance time was used as
criterion of exercise capacity and compared with data
reported previously [21,22].
Neuropsychological assessment
Cognitive development
A short version of the Revised Amsterdam Intelligence Test
(RAKIT) for children was used to evaluate cognitive develop-
ment. The RAKIT is a well-known standardised instrument in
The Netherlands for children aged 4–11 years. Good reliability
and validity have been demonstrated [23,24]. The short ver-
sion contains six subtests. The raw subtest scores are con-
verted into standardised scores, which are then transformed
into a short RAKIT intelligence quotient (IQ) with a mean of
100 and a SD of 15. Cognitive delay was defined by a test
result more than -1 SD below the norm (that is to say, IQ ≤ 85).
Visual–motor integration
The Developmental Test of Visual–Motor Integration for chil-
dren aged from 3 to 18 years measures the integration of vis-
ual perceptual and motor abilities [25]. Children are asked to
copy figures of increasing geometric complexity. The com-
puted raw item scores are transformed into a visual–motor
integration standard score with a mean of 100 and a SD of 15.
Table 1
Assessment protocol at 5 years of age
Time (hours) Instrument Nijmegen Rotterdam
Medical assessment (paediatrician) 1 Physical and neurological examination X X
Neuromotor assessment (paediatric 
physiotherapist)
1.5 Movement Assessment Battery for Children X X
Exercise test X
Neuropsychological assessment 
(psychologist and speech therapist)
3
Intelligence Revised Amsterdam Intelligence Test/
Wechsler Intelligence Scale for Children
XX
Visual – motor integration Beery X
Receptive language development Reynell X X
Expressive language development Schlichting X X
Behaviour Child Behaviour Checklist/Teacher's Report 
Form
XXCritical Care    Vol 10 No 5    Hanekamp et al.
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Behaviour
The Dutch versions of the Child Behaviour Checklist and the
Teacher's Report Form were completed by parents and teach-
ers, respectively [26,27]. Both have been standardised for the
Dutch population from 4 to 18 years old, and rate 120 problem
behaviour items on a three-point scale (0 = not true, 1 = some-
what true or sometimes true, 2 = very true or often true)
[28,29]. A total problem score is computed by summing the
scores of all items. Two broadband scales were constructed:
an internalising scale including withdrawn behaviour, somatic
complaints without physical cause, and anxious-depressive
feelings; and an externalising scale including aggressive and
delinquent behaviour. Total scores ≥60 classify children in the
borderline/clinical range.
Language development
Language development was assessed with the Reynell Test
and the Schlichting Test. The Reynell test assesses receptive
language development of Dutch-speaking children between
ages 1 and 6 years [30]. Expressive language is not required
since the children may respond nonverbally.
The Schlichting Test assesses language expression of Dutch-
speaking children between ages 1 and 6 years [31]. Two sub-
tests were applied: one testing knowledge of grammatical
structure (syntactical development), and the other subtest
measuring active vocabulary (lexical development).
The numbers of correct answers in the tests were transformed
into standard quotient scores with a mean of 100 and a SD of
15. The following categories were discerned: delayed/abnor-
mal development (score less than -2 SD), at risk (score from -
1 SD to -2 SD), and normal (score greater than -1 SD).
Data analysis
Data are presented for the entire group and also by diagnosis.
An independent-sample Student t test was performed when
appropriate to analyse differences between the study group
and general population norms. P < 0.05 represented statisti-
cal significance.
A chi-square test was performed to test whether the motor
performance scores in this ECMO population differed signifi-
cantly from the distribution in the normal population. P < 0.05
was considered statistically significant.
Results
A total of 144 neonates received venoarterial-ECMO support
from January 1996 up to and including December 1998.
Thirty-one of them (22%) died before age 5 years, all during
first admission at median age 21 days (interquartile range, 11–
35 days; range, 2–120 days). Fourteen infants were lost to fol-
low-up for various reasons. The present addresses of two chil-
dren could not be traced, the families of three children moved
abroad, and parental consent was withheld for five children.
Four other children failed to appear, even after repeated invita-
tions. Ninety-nine infants therefore participated in the follow-
up programme (Figure 1). The parents of one child, however,
withheld consent to use data for publication purposes, so
eventually we present data of 98 children (35 children in Rot-
terdam, 63 children in Nijmegen) (87% of all survivors).
The perinatal characteristics and ECMO-treatment character-
istics of the participants are presented in Table 2. The
children's basic characteristics at time of follow-up are pre-
sented in Table 3.
Outcome medical assessment
Seventeen children (17%) were found to have a neurological
disorder. Six of those (6%) showed major neurodevelopmental
disability, including two children with a chromosomal abnor-
mality. Of the latter, one child was known to have Down syn-
drome and the second child (diagnosed with CDH) showed
unbalanced translocation of chromosome 11–22 (unknown at
the time of ECMO). This boy was severely impaired and men-
tally retarded, and is known to have died at age six years.
Of the other four children with major neurological disorder,
one had a right-sided hemiplegia caused by nonhaemorrhagic
i n f a r c t i o n  d u r i n g  E C M O .  H e  w a l k e d  w i t h  a n  o r t h e s i s  a n d
attended special education. The second child had developed
a right-sided hemiplegia as a result of left-sided cerebral hemi-
atrophy. He was confined to a wheelchair and was mentally
retarded. The third child with major neurological disorder
(diagnosed with meconium aspiration syndrome) had severe
asphyxia and had been resuscitated in the immediate postna-
Figure 1
Flowsheet of infants included in the follow-up programme Flowsheet of infants included in the follow-up programme. VA-EMCO, 
venoarterial extracorporeal membrane oxygenation.Available online http://ccforum.com/content/10/5/R127
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tal period. Still suffering from a seizure disorder, she used a
walking frame, and she was mentally retarded. The fourth child
suffered from seizures, used a wheelchair, and was mentally
retarded.
Eleven children (11%) showed minor neurological dysfunc-
tion, varying from strength differences in the upper and lower
extremities to very mild hemiplegia and a mild form of West
syndrome (one child).
The mean (SD score) weight and height for the entire popula-
tion were -0.5 (1.5) and -0.4 (1.2), respectively (Table 3). Both
parameters were significantly below zero (P = 0.001 and P =
0.002, respectively).
Eighteen children (18%) had respiratory complaints. Twelve of
them regularly used a combination of β-sympathicomimetic
drugs and inhalation steroids. None of the children needed
supplemental oxygen. Two of the total population were fol-
lowed because of a muscular ventricular septal defect, without
Table 2
Perinatal and extracorporeal membrane oxygenation (ECMO) characteristics
Male/female 60/38
Birthweight (kg) 3.3 (2.9–3.8)
Gestational age (weeks) 40 (38–41)
Apgar score at 1 minute/5 minutes 5/7
Primary diagnosis
Meconium aspiration syndrome 51
Congenital diaphragmatic hernia 20
Sepsis 11
Persistent pulmonary hypertension of the newborn 15
Congenital cystic adenoid malformation of the lung 1
Outborn (n)
Home 10
>20 km from ECMO centre 51
<20 km from ECMO centre 30
Oxygenation index prior to ECMOa 39 (24–58)
Alveolar arterial oxygen distention gradientb 622 (606–637)
Age at start of ECMO (hours) 28 (17–43)
Duration of ECMO support (hours) 155 (127–188)
Duration of mechanical ventilation (days) 16 (13–22)
Supplemental oxygen after ECMO (days) 8 (4–16)
Duration of first admission (days) 38 (30–55)
Haemorrhagic intracranial abnormalities (n)
Minor: intraventricular haemorrhage grade 1 and grade 2 8
Major: intraventricular haemorrhage grade 3 and grade 4 0
Nonhaemorrhagic intracranial abnormalities (n)
Minor: ventricular dilatation and focal atrophy 17
Major: general atrophy and infarcts 4
Observed infants with epileptic insults (n)2 7
Patients treated with phenobarbital as prophylaxis (n)3 7
Duration of phenobarbital treatment in infants with epileptic insults (days) 49 (21–90)
Perinatal characteristics of the 98 children available for analysis, presented as n (%) of infants or median (interquartile range). aCalculated as 
[(mean airway pressure × FiO2)/PaO2] × 100. bCalculated as Patm – PH2O – PaO2 – PaCO2 (PaO2 and PaCO2 in mmHg).Critical Care    Vol 10 No 5    Hanekamp et al.
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haemodynamic consequences; one because of atrial septal
defect. One of the 20 children diagnosed with CDH was still
on (nightly) tube feeding because of low weight (-3.4 SD) and
pulmonary problems, and a second child had received tube
feeding until his fourth birthday. The child who was known with
unbalanced translocation of chromosome 11–22 was fed
through a gastrostomy drain and had undergone a Nissen fun-
doplication because of gastrooesophageal reflux. Another
child, not diagnosed with CDH, was also fed through a gas-
trostomy drain.
Outcome neuromotor assessment
Excluding the six children with major neurodevelopmental dis-
ability, 92 of the 98 children were tested using the M-ABC.
Twenty-four children (26.1%) were classified as having some
kind of motor difficulty (percentile score < P 15), which repre-
sents a significantly higher proportion than expected (chi-
square test, P < 0.005).
Fourteen children (15.2%) had scores indicative of a motor
problem (percentile score < P 5) (chi-square test, P < 0.001),
10 children (10.9%) had borderline performance (percentile
score < P 15 but > P 5), and 68 children (73.9%) performed
normally (percentile score > P 15) (Table 4).
A comparison with population norms revealed that the mean
(SD) M-ABC score of the total group was significantly below
the reference value: 8.4 (8.1) versus 5.2 (5.6) (P < 0.001)
[18].
Table 3
Basic characteristics of the study group at 5 years of age
Total group (n = 98)
Males/females 60/38
Age (months) 62 (3.0)
Weight SD score -0.5 (1.5)*
Height SD score -0.4 (1.2)**
Weight for height SD score -0.4 (1.4)***
Socioeconomic status (%)
High 26 (27)
Normal 49 (50)
Low 19 (19)
Unknown 4 (4)
Ethnic group (%)
White 85 (87)
African 3 (3)
Asian 1 (1)
Turkish or Moroccan 9 (9)
Data presented as n (%) of patients or mean (standard deviation (SD)). The mean weight, height and weight for height (SD scores) for the entire 
population were all significantly below zero: * P = 0.001, ** P = 0.002, *** P = 0.008. Children with congenital diaphragmatic hernia had 
significantly lower height and weight than children with meconium aspiration syndrome (P < 0.001).
Table 4
MovementAssessment Battery for Children results
Total group (n = 92) Meconium aspiration 
syndrome (n = 49)
Congenital diaphragmatic 
hernia (n = 19)
Sepsis (n = 11) Persistent pulmonary hypertension 
of the newborn (n = 12)
Total impairment score (mean 
(standard deviation))
8.4 (8.1)* 6.8 (6.6) 13.4 (10.3) 7.5 (7.5) 7 (7.1)
Score < P 5, motor problem (n (%)) 14 (15.2%)** 3 (6.1) 7 (36.8) 1 (9.1) 2 (16.7)
Score P 5–P 15, borderline (n (%)) 10 (10.9%) 3 (6.1) 4 (21.1) 2 (18.2) 1 (8.3)
Score > P 15, normal (n (%)) 68 (73.9%)*** 43 (87.8) 8 (42.1) 8 (72.7) 9 (75)
*t test: significant, P < 0.001. ** Chi-square test: significant, P < 0.001. ***Chi-square test: significant, P < 0.005.Available online http://ccforum.com/content/10/5/R127
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Twenty-nine of the 35 children seen in Rotterdam performed
the exercise test according to the Bruce protocol (Table 5).
Five children with major neurological impairment could not
perform the test. One child (diagnosed with CDH) was too
anxious to use the treadmill and performed a six-minute walk-
ing test instead. The height and weight of the 29 children (15
boys) were expressed as SD scores. These were not signifi-
cantly below or above the reference value (SD = 0) and there
were no significant differences between boys and girls. Com-
parison of endurance times with the Canadian norms reported
by Cumming and colleagues [21] revealed a significantly
lower mean (SD) endurance time for the boys: 9.0 (1.2) versus
10.4 (1.9) (P < 0.005). The mean endurance time for the girls
was not significantly different: 9.2 (1.8) versus 9.5 (1.8) (P =
0.6).
Outcome neuropsychological assessment
To create a mutually comparable group, three children with
chromosomal or syndromal abnormalities as well as 11 chil-
dren who did not speak Dutch as their native language and
Table 5
Exercise test
Total group (n = 29) Boys (n = 15) Girls (n = 14)
Endurance time (minutes) (mean (standard deviation)) 9.0 (1.2)* 9.2 (1.8)
Less than -2 SD, abnormal (n (%)) 1 (3.4%) 0 1
-1 SD to -2 SD, suspect (n (%)) 8 (27.6%) 7 1
Greater than -1 SD, normal (n (%)) 20 (69.0%) 8 12
Score according to Cumming and colleagues [21]. *t test: significant, P < 0.001.
Table 6
Neuropsychological outcome
Total group (n = 82)
Intelligence quotient (n = 79) 100.5 (19.7)
70–85 4 (5.1%)
51–70 3 (3.9%)
≤50 4 (5.1%)
Expressive language (n = 78)
Grammar 104.2a (17.9)
70–85 11 (14.1%)
51–70 2 (2.6%)
≤50 --
Vocabulary 103.2 (19.6)
70–85 6 (7.8%)
51–70 5 (6.5%)
≤50 2 (2.6%)
Receptive language (n = 81) 104.3a (15.3)
70–85 1 (1.2%)
51–70 5 (6.1%)
≤50 --
Visual – motor integration (n = 28) 96.6 (13.7)
70–85 7 (25%)
51–70 --
≤50 --
Data presented as the mean (standard deviation) or as n (% of total number). aSignificant difference (P < 0.05) from the Dutch population norm.Critical Care    Vol 10 No 5    Hanekamp et al.
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one child with severe hearing problems were excluded from
data analysis. One child's data on all neuropsychological tests
were lost, leaving 82 children for analysis. For three children all
data on cognitive development were missing. Three children
could not be successfully tested on expressive language, and
one child could not be tested either on expressive or on recep-
tive language. Visual–motor integration in Rotterdam was
tested in 28 out of 35 children. Major neurological impairment
precluded testing in five children and the data of two other
children were missing. The neuropsychological outcome data
are presented in Table 6.
Cognitive development
Eleven children (14.1%) showed cognitive delay. The mean
RAKIT score of the total group (IQ = 100.5) did not differ sig-
nificantly from the Dutch norm.
Language development
In the expressive language test, 13 children (16.7%) scored ≥
1 SD below the norm on grammar and vocabulary. In the
receptive language test, six children (7.3%) scored ≥ 1 SD
below the norm. The mean scores on grammar and receptive
language were significantly above the Dutch norm.
Visual–motor integration
Seven children (25%) scored ≥ 1 SD below the norm. The
mean score of the total group did not differ significantly from
the Dutch norm.
Behaviour
The results of the Child Behaviour Checklist are presented in
Table 7. Of all children, 12.8% had a total problem score
above 63, indicating behavioural problems. Internalising prob-
lems occurred slightly more than did externalising problems.
Discussion
The present report presents nationwide neurodevelopmental
sequelae of 98 venoarterial-ECMO-treated neonates at age 5
years (87% of all survivors). Seventeen children (17%) pre-
sented with major or minor neurological disorders. Another 24
children (26.1%) of the children who participated in the neu-
romotor assessment presented with some kind of motor diffi-
culty, 14 of whom (15.2%) had an actual motor problem and
10 of whom (10.9%) were at risk for a motor problem. Cogni-
tive delays were identified in 11 children (14% of 82 analysed
children).
Two of the 17 children with neurological disability had a chro-
mosomal disorder accounting for neurological impairment,
and one child had West syndrome associated with mental
retardation and seizures. Four of the remaining 14 patients
(14%) had major neurological impairment and 10 children had
minor neurological impairment without an underlying disorder.
Our findings seem not completely consistent with findings
reported by Glass and colleagues [17] in 103 children: 17%
of children in that study had one or more major disability versus
14% in our group. Glass and colleagues, however, ranked
mental disability, as well as motor disability and seizure disor-
ders, also under major disability. Had we included children
who scored abnormal in the medical assessment, motor
assessment, or mental assessment as well, we would have
found a similar proportion (17%).
The UK ECMO Trial Group has reported on the outcome of
ECMO-treated neonates at age 4 years [16]. A consistent
Table 7
Child Behaviour Checklist (n = 86)
Total problem score
<60 72 (83.5%)
60–63 5 (5.9%)
>63 9 (10.5%)
Internal problem score
<60 72 (83.7%)
60–63 7 (8.1%)
>63 7 (8.1%)
External problem score
<60 76 (88.4%)
60–63 6 (7.0%)
>63 4 (4.7%)
Data presented as number of patients (%). The internal scale includes withdrawn behaviour, somatic complaints without physical cause, and 
anxious-depressive feelings. The external scale includes aggressive and delinquent behaviour. Scores ≥60 but <63 are in the borderline range. 
Scores ≥63 are in the clinical range.Available online http://ccforum.com/content/10/5/R127
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comparison is hampered by the fact that methods were differ-
ent. In the United Kingdom one paediatrician assessed the
children in six clinical domains, including cognitive ability, neu-
romotor skills, general health, behaviour, vision, and hearing.
Nineteen per cent of the children had test scores outside the
normal range. With regard to 'disability', 13% of the children
were moderately to severely disabled, which is consistent with
the 14% we report.
The rate of motor difficulties in our cohort was 26% (score <
P 15); 15% of the children had an abnormal motor score
(score < P 5). This 15% we found exceeds the 6% reported
by Glass and colleagues [17]. Unfortunately, few follow-up
studies have used standardised tests such as the M-ABC to
assess neuromotor outcome. Even in our study some of the
children with minor motor difficulties were assessed normal at
neurological examination. In the M-ABC assessment, however,
the children are stressed to move under velocity or accuracy
demands. Such circumstances are more sensitive to detect
motor performance problems. It is essential, therefore, that
professionals with specific experience should assess the
developmental domains in the context of a structured follow-
up programme.
In our study 29 children performed a maximum exercise test.
The maximal endurance time was used as the criterion of exer-
cise capacity, and we compared outcomes with the data pre-
sented by Cumming and colleagues [21]. Binkhorst and
colleagues in 1992 published references values for normal
exercise performance in Dutch boys and girls aged 4–18
years using the Bruce treadmill protocol [22]. The authors
included few 4 year olds and the number of 6 year olds is
unclear, however, and they did not provide means and SDs for
these ages. This is why we did not use these Dutch reference
values. Nevertheless, 41% of the children in our study would
score below the 5th percentile according to these Dutch ref-
erence values. The question is whether this can be explained
by impaired physical condition of ECMO-treated patients or by
the fact that the reference values established by Binkhorst and
colleagues insufficiently reflect the exercise performance of
contemporary healthy Dutch children. Future studies are
needed and will be performed in Erasmus MC – Sophia Chil-
dren's Hospital in the near future.
Follow-up at age 5 is important because children are in their
first year or second year of primary school, at the start of their
further school career. Eleven children (14%) showed cognitive
delay, a proportion comparable with that reported by Glass
and colleagues (13%). The IQ summary scores are compara-
ble as well: 100 in our cohort versus 96 in their study.
Although in the UK ECMO trial cognitive ability at age 4 did not
show evidence of a difference between the two trial groups,
23% of ECMO-treated children showed cognitive delay
(defined as IQ greater than -1 SD) [16].
Behavioural problems beyond the clinical cutoff point were
identified in 11 children in our cohort. These problems might
contribute to school failure, even in the absence of cognitive
delay [32].
Language development scores were all above population
norms. Children without Dutch as their native language who
had difficulty understanding and speaking Dutch were, how-
ever, excluded from these tests. Still, language development
seems unaffected.
In the absence of a matched control group it remains difficult
to establish to what extent ECMO treatment contributes to the
outcome. The UK ECMO trial did show a benefit of ECMO
based on the primary outcome of death or severe disability.
Children were assessed at age 4 in six different domains (cog-
nitive ability, neuromotor skills, general health, behaviour,
vision, and hearing). The trial defined outcome as normal,
impaired, or disabled on the basis of the degree of functional
loss in any of the domains. There was no evidence of signifi-
cant difference regarding cognitive ability and motor disability
between the conventional treatment and ECMO groups. The
overall rate of moderate disability in the conventional group
was 11% versus 13% in the ECMO group. Severe disability
was only reported in the ECMO group (that is to say, 3%) [16].
The rate of disability (that is to say, cerebral palsy) reported in
a study of 89 surviving children with moderate to severe peri-
natal asphyxia at age 8 years was 15%. Ten per cent of chil-
dren had profound cognitive delay [33]. The intelligence
quotient in a group of nondisabled children with mild and mod-
erate perinatal asphyxia was 106 (± 14) [33]. These propor-
tions are in the same range as the proportions reported in the
present study.
Since all infants received venoarterial ECMO, would veno-
venous ECMO improve cognitive or neuromotor outcome?
When using the Extracorporeal Life Support Organisation
Registry [1], no significant difference in primary outcome
between venovenous ECMO and venoarterial ECMO has
been reported [34].
Conclusion
The outcome figures of ECMO-treated neonates at follow-up
at age 5 years presented in the present study show consider-
able morbidity, but they do not greatly differ from those
reported in previous publications on ECMO-treated neonates
[16,17]. The high response rate of 87% (versus 61% by Glass
and colleagues [17]) was feasible for various reasons: coop-
eration between two centres, small travelling distances, as
well as the quality of the health care system in The Nether-
lands. We believe that a successful follow-up programme of
severely ill neonates should be structured in consultation with
representatives from different disciplines, such as a paediatri-
cian, a paediatric physiotherapist, a psychologist, and a
speech therapist. Further longitudinal follow-up studies willCritical Care    Vol 10 No 5    Hanekamp et al.
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focus on the relationship between neonatal status and test
results at 5 years and on detailed analysis of the different
domains. Within the framework of the nationwide follow-up
programme, longitudinal data at ages 8 and 12 years are
expected to become available in due time.
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